Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015832
Filing Date
2025-06-05
Accepted
2025-06-05 18:01:14
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 form4-06052025_060604.html 4  
1 form4-06052025_060604.xml 4 3649
  Complete submission text file 0001415889-25-015832.txt   5105
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 251028427